CDC wants more input before updating post-exposure guidelines. Centers for Disease Control and Prevention.
D000998:Antiviral Agents / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D017408:Guidelines as Topic; D015658:HIV Infections / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D006679:HIV Seropositivity; D006282:Health Personnel; D017758:Infectious Disease Transmission, Patient-to-Professional; D007342:Insurance Benefits; D016602:Needlestick Injuries; D016273:Occupational Exposure; D014481:United States; D015215:Zidovudine / Q000627:therapeutic use
D000998:Antiviral Agents; D015215:Zidovudine